Erwei Hao

1.8k total citations
103 papers, 1.2k citations indexed

About

Erwei Hao is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Erwei Hao has authored 103 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 18 papers in Pharmacology and 17 papers in Complementary and alternative medicine. Recurrent topics in Erwei Hao's work include Natural product bioactivities and synthesis (11 papers), Pharmacological Effects of Natural Compounds (9 papers) and Natural Antidiabetic Agents Studies (7 papers). Erwei Hao is often cited by papers focused on Natural product bioactivities and synthesis (11 papers), Pharmacological Effects of Natural Compounds (9 papers) and Natural Antidiabetic Agents Studies (7 papers). Erwei Hao collaborates with scholars based in China, Macao and Taiwan. Erwei Hao's co-authors include Jiagang Deng, Xiaotao Hou, Zhengcai Du, Gang Bai, Chung‐Der Hsiao, Yu‐Heng Lai, Jinling Xie, Jung‐Ren Chen, Gilbert Audira and Yuanyuan Hou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Food Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Erwei Hao

93 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erwei Hao China 21 432 185 155 154 105 103 1.2k
Chieh‐Hsi Wu Taiwan 21 511 1.2× 192 1.0× 138 0.9× 143 0.9× 87 0.8× 41 1.2k
Su Jung Hwang South Korea 16 541 1.3× 163 0.9× 91 0.6× 115 0.7× 66 0.6× 44 1.3k
JI Yu-bin China 19 539 1.2× 185 1.0× 99 0.6× 119 0.8× 45 0.4× 96 1.2k
Young‐Min Ham South Korea 22 552 1.3× 294 1.6× 115 0.7× 101 0.7× 70 0.7× 56 1.3k
Liwen Han China 22 536 1.2× 140 0.8× 102 0.7× 151 1.0× 172 1.6× 75 1.2k
Nikolaus Bresgen Austria 20 668 1.5× 252 1.4× 194 1.3× 99 0.6× 100 1.0× 57 1.8k
Ki Cheon Kim South Korea 24 905 2.1× 192 1.0× 124 0.8× 126 0.8× 122 1.2× 71 1.8k
Na Young Yoon South Korea 22 575 1.3× 192 1.0× 135 0.9× 126 0.8× 140 1.3× 49 1.6k
Wenwen Jin China 18 457 1.1× 176 1.0× 120 0.8× 68 0.4× 77 0.7× 74 1.3k

Countries citing papers authored by Erwei Hao

Since Specialization
Citations

This map shows the geographic impact of Erwei Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwei Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwei Hao more than expected).

Fields of papers citing papers by Erwei Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwei Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwei Hao. The network helps show where Erwei Hao may publish in the future.

Co-authorship network of co-authors of Erwei Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Erwei Hao. A scholar is included among the top collaborators of Erwei Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwei Hao. Erwei Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yingying, Jing Hou, Hai‐Xia Cao, et al.. (2025). High-altitude immune remodeling in children with Mycoplasma pneumoniae pneumonia: a multi-center transcriptome study. Frontiers in Immunology. 16. 1704739–1704739.
2.
Deng, Jiagang, et al.. (2025). Exploring the Potential Mechanism of Liupao Tea Using UPLC-Q-TOF/MS and Network Pharmacology. Pharmaceuticals. 18(3). 294–294. 1 indexed citations
3.
4.
Fan, Lili, et al.. (2024). Concentration-Dependent bidirectional regulation of adenosine receptor A1 explored through machine learning. Computational and Theoretical Chemistry. 1235. 114551–114551. 1 indexed citations
5.
Wang, Xiangying, Xiao Yang, Erwei Hao, et al.. (2024). An Efficient Integrated Strategy for Comprehensive Metabolite Profiling of Sakurasosaponin from Aegiceras corniculatum in Rats. Current Drug Metabolism. 25(5). 340–354.
6.
Lian, Jing, Huaying Li, Fan Zhang, et al.. (2024). Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway. Frontiers in Cell and Developmental Biology. 12. 1431423–1431423. 9 indexed citations
7.
Tang, Jiajun, Jiagang Deng, Erwei Hao, et al.. (2024). Research on the Mechanism and Material Basis of Corn (Zea mays L.) Waste Regulating Dyslipidemia. Pharmaceuticals. 17(7). 868–868. 5 indexed citations
8.
Yuan, Renyikun, Jia He, Ming Yang, et al.. (2023). Sugarcane leaf polysaccharide exerts a therapeutic effect on cardiovascular diseases through necroptosis. Heliyon. 9(11). e21889–e21889. 8 indexed citations
9.
Wen, Hao, et al.. (2023). Development of a novel hypochlorite ratio probe based on coumarin and its application in living cells. RSC Advances. 13(46). 32518–32522. 3 indexed citations
10.
Gao, Jie, et al.. (2023). Glucuronic acid metabolites of phenolic acids target AKT-PH domain to improve glucose metabolism. Chinese Herbal Medicines. 15(3). 398–406. 10 indexed citations
11.
Zhao, Mingming, Ke‐Gang Linghu, Tianyi Hua, et al.. (2022). Anti-inflammatory/anti-oxidant properties and the UPLC-QTOF/MS-based metabolomics discrimination of three yellow camellia species. Food Research International. 160. 111628–111628. 22 indexed citations
12.
Li, Zeyu, Erwei Hao, Rui Cao, et al.. (2022). Analysis on internal mechanism of zedoary turmeric in treatment of liver cancer based on pharmacodynamic substances and pharmacodynamic groups. Chinese Herbal Medicines. 14(4). 479–493. 12 indexed citations
13.
Hao, Erwei, et al.. (2021). Identifying Active Compounds and Mechanism of Camellia nitidissima Chi on Anti-Colon Cancer by Network Pharmacology and Experimental Validation. Evidence-based Complementary and Alternative Medicine. 2021. 1–15. 8 indexed citations
14.
Zhang, Fan, Zhengcai Du, Jinling Xie, et al.. (2021). Proteome Analysis of Camellia nitidissima Chi Revealed Its Role in Colon Cancer Through the Apoptosis and Ferroptosis Pathway. Frontiers in Oncology. 11. 727130–727130. 28 indexed citations
15.
Hou, Xiaotao, Erwei Hao, Jinling Xie, et al.. (2021). Analysis on oral medication rules of traditional Chinese medicine prescriptions for prevention of COVID-19. Chinese Herbal Medicines. 13(4). 502–517. 14 indexed citations
16.
Hao, Erwei, Wei Wei, Jianhua Miao, et al.. (2020). Identification and Analysis of Components in Yizhi Granule and Cynomolgus Monkey Plasma after Oral Administration by UPLC/ESI-Q-TOF MS and Their Protective Effects on PC12 Cells. Journal of Analytical Methods in Chemistry. 2020. 1–14. 5 indexed citations
17.
18.
Hao, Erwei. (2013). Analysis on Theoretical Origin of Chinese Medicine with Neutral Property. Zhonghua zhongyiyao xuekan. 1 indexed citations
19.
Hao, Erwei. (2012). The Effect of Mangiferin on Spontaneously Hypertensive Rats' Heart, Brain and Kidney Tissue Morphology. Science Technology and Engineering. 1 indexed citations
20.
Hao, Erwei. (1980). A NEW SUBSPECIES OF PHRYNOCEPHALUS VLANGALII (STRAUCH) AND PRELIMINARY OBSERVATIONS ON ITS ECOLOGY. Dongwu xuebao. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chieh‐Hsi Wu Breakdown of academic impact, for papers by Su Jung Hwang Breakdown of academic impact, for papers by JI Yu-bin Breakdown of academic impact, for papers by Young‐Min Ham Breakdown of academic impact, for papers by Liwen Han Breakdown of academic impact, for papers by Nikolaus Bresgen Breakdown of academic impact, for papers by Ki Cheon Kim Breakdown of academic impact, for papers by Na Young Yoon Breakdown of academic impact, for papers by Wenwen Jin
Rankless by CCL
2026